Rilaxta VRx, which is Cynergi’s software, will be used in combination with other treatments provided at NeuPath, as part of the collaboration
NeuPath and Cynergi will work together to develop a combined offering. (Credit: Julio César Velásquez Mejía/Pixabay)
NeuPath Health has entered into a memorandum of understanding (MoU) with Cynergi Health Partners to assess the efficacy of Cynergi’s virtual reality (VR) programme for chronic pain management.
As part of the collaboration, Rilaxta VRx, which is Cynergi’s software, will be used in combination with other treatments provided at NeuPath.
Both firms will work together to develop and co-market a combined offering, which includes Rilaxta VRx and NeuPath’s remote pain management and virtual care platform in Canada and the US.
NeuPath CEO Grant Connelly said: “Working with a leading group like Cynergi allows us to bring innovative, behavioral pain treatments to our patients. In addition, collaborating with Cynergi and co-marketing Rilaxta VRx with NeuPath’s virtual care platform creates a compelling offering that will open new markets in Canada and the US.”
NeuPath, a vertically integrated health care provider, uses research, data-driven insights, technology and interdisciplinary care to help reinforce function for patients affected by chronic pain, spinal injuries, sport-related injuries, and concussions.
It has equity ownership in fifteen clinics in Ontario and Alberta.
Cynergi Health Partners, a provider of addiction medicine and psychiatry services, facilitates access a network of physicians, medical detox services, advanced technology and detox protocols.
Its virtual reality software will help minimise and mitigate withdrawal symptoms of anxiety or panic associated with alcohol, opiate, and benzodiazepine addiction.
Cynergi CEO Dr Harbir Singh said: “Collaborating with NeuPath and building a holistic chronic pain targeted treatment program provides an outstanding opportunity to work with employers and other payers to improve patient quality of life while also reducing disability related costs as well as other direct health care costs.”